Σύγκριση μεθόδων

	WHOQOL-BREF	Duke Health Profile	EQ-5D
Πεδίο	Μετρήσεις Υγείας	Μετρήσεις Υγείας	Μετρήσεις Υγείας
Οικογένεια	Process / pipeline	Process / pipeline	Process / pipeline
Έτος προέλευσης	1998	1989	1990
Δημιουργός	World Health Organization Quality of Life Group	George R. Parkerson and colleagues at Duke University	EuroQol Group
Τύπος	Multidimensional quality of life assessment	Multidimensional health status assessment	Generic preference-based health utility measure
Θεμελιώδης πηγή	The WHOQOL Group. (1998). Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychological Medicine, 28(3), 551–558.	Parkerson, G. R., Connis, R. T., Gehlbach, S. H., et al. (1989). The Duke Health Profile: a 17-item measure of health-related quality of life. Medical Care, 28(11), 1056–1072.	Rabin, R., & de Charro, F. (2001). EQ-5D: a measure of health status from the EuroQol Group. Annals of Medicine, 33(5), 337–343.
Εναλλακτικές ονομασίες	WHOQOL-BREF Questionnaire, WHO Quality of Life-BREF	DUKE, Duke Health Status Measure	EQ-5D-3L, EQ-5D-5L, EuroQol
Συναφείς	5	5	5
Σύνοψη	The WHOQOL-BREF is the brief version of the World Health Organization's quality of life assessment, developed by the WHO Quality of Life Group and published in 1998. It measures quality of life across physical, psychological, social, and environmental domains in a single 26-item self-report questionnaire. It has become the primary quality of life instrument in global health research and clinical practice.	The Duke Health Profile (DUKE) is a 17-item self-report measure of health-related quality of life developed by Parkerson and colleagues at Duke University in 1989. It assesses health across six dimensions: physical function, mental health, social function, general health perceptions, anxiety, and depression. The instrument combines brevity with multidimensional assessment, making it practical for clinical and research settings.	The EQ-5D is a standardized, preference-based health utility measure developed by the EuroQol Group in 1990. It combines a descriptive health profile (five dimensions, three or five response levels) with a visual analog scale to quantify overall health status. The instrument has become essential for health economics, clinical trials, and cost-effectiveness analysis worldwide.